By Kayla Matthews, freelance journalist, Productivity Bytes.
Precision medicine involves formulating treatments for individualized patients, typically with genetic sequencing that could shed light on the underlying causes of disease. It’s an amazing idea that could substantially reduce the likelihood of the same treatment curing one person and failing to help another.
However, some things still hold precision medicine back. Here are six ways it could advance.
1. Lower Research and Development Costs
Statistics indicate precision medicine is gaining momentum. For example, 70% of cancer drugs in development are precision-based, and 20% of research and development in the pharmaceutical sector relates to precision medicine.
Those are promising signs, but cost remains a significant factor that slows down the advancement of precision medicine. The research and development associated with it is more expensive than standard approaches because it involves genetic testing. Companion testing is often required to find biomarkers, as well as marker-negative patients.
Securing financial backing can be tricky, especially if investors or the financial decision-makers at pharmaceutical companies are still dubious about precision medicine’s potential.
2. More Patient Education
Many patients have heard about precision medicine in passing, but they don’t know what it entails or how to avail of it. Intermountain Healthcare, a Utah-based health system with nearly two dozen locations, found that a lack of patient education restricted its adoption of precision medicine. The organization began automatically referring metastatic cancer patients to a research clinic that used precision medicine.
There, patients had access to a proprietary system that checked for more than 160 genetic mutations associated with cancer by examining portions of a person’s genetic code. Then, people from a molecular tumor board interpreted the results, guiding doctors in setting up treatment plans for their patients.